Following this program, participants should be able to:
List the appropriate pathology techniques for diagnostic and prognostic modeling for patients with hematologic malignancies
Identify the available therapeutic options for acute lymphocytic leukemia, cutaneous T-cell lymphoma, Hodgkin’s lymphoma, chronic myelogenous leukemia, and multiple myeloma
Describe the role of PET in the diagnosis and management of lymphomas
Define best practices for the management of supportive care issues with anemia and myelodysplastic syndromes
Compare and contrast the risks and benefits of using ESAs in cancer care
Recognize the challenges presented by advanced directives with advancing disease
